AU2003226725A1 - Pyrazolopyrimidine derivatives - Google Patents

Pyrazolopyrimidine derivatives

Info

Publication number
AU2003226725A1
AU2003226725A1 AU2003226725A AU2003226725A AU2003226725A1 AU 2003226725 A1 AU2003226725 A1 AU 2003226725A1 AU 2003226725 A AU2003226725 A AU 2003226725A AU 2003226725 A AU2003226725 A AU 2003226725A AU 2003226725 A1 AU2003226725 A1 AU 2003226725A1
Authority
AU
Australia
Prior art keywords
pyrazolopyrimidine derivatives
pyrazolopyrimidine
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003226725A
Other versions
AU2003226725A8 (en
Inventor
Jason Witherington
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of AU2003226725A1 publication Critical patent/AU2003226725A1/en
Publication of AU2003226725A8 publication Critical patent/AU2003226725A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AU2003226725A 2002-03-27 2003-03-25 Pyrazolopyrimidine derivatives Abandoned AU2003226725A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0207246.0A GB0207246D0 (en) 2002-03-27 2002-03-27 Novel compounds
GB0207246.0 2002-03-27
PCT/EP2003/003196 WO2003080617A1 (en) 2002-03-27 2003-03-25 Pyrazolopyrimidine derivatives

Publications (2)

Publication Number Publication Date
AU2003226725A1 true AU2003226725A1 (en) 2003-10-08
AU2003226725A8 AU2003226725A8 (en) 2003-10-08

Family

ID=9933830

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003226725A Abandoned AU2003226725A1 (en) 2002-03-27 2003-03-25 Pyrazolopyrimidine derivatives

Country Status (3)

Country Link
AU (1) AU2003226725A1 (en)
GB (1) GB0207246D0 (en)
WO (1) WO2003080617A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1928437A2 (en) 2005-08-26 2008-06-11 Braincells, Inc. Neurogenesis by muscarinic receptor modulation
EP2258359A3 (en) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenesis by muscarinic receptor modulation with sabcomelin
EP1940389A2 (en) 2005-10-21 2008-07-09 Braincells, Inc. Modulation of neurogenesis by pde inhibition
CA2625210A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
AU2007219509A1 (en) * 2006-01-18 2007-09-07 Siena Biotech S.P.A Modulators of alpha7 nicotinic acetylcholine receptors and therapeutic uses thereof
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
EP2377531A2 (en) 2006-05-09 2011-10-19 Braincells, Inc. Neurogenesis by modulating angiotensin
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5593997A (en) * 1995-05-23 1997-01-14 Pfizer Inc. 4-aminopyrazolo(3-,4-D)pyrimidine and 4-aminopyrazolo-(3,4-D)pyridine tyrosine kinase inhibitors
WO2001081345A1 (en) * 2000-04-20 2001-11-01 Mitsubishi Pharma Corporation Aromatic amide compounds
AU2001287898A1 (en) * 2000-09-22 2002-04-02 Stephen Garland Pyrazolopyridines and pyrazolopyridazines as antidiabetics
WO2002050073A1 (en) * 2000-12-19 2002-06-27 Smithkline Beecham P.L.C. Pyrazolo[3,4-c]pyridines as gsk-3 inhibitors
GB0100621D0 (en) * 2001-01-10 2001-02-21 Vernalis Res Ltd Chemical compounds VI

Also Published As

Publication number Publication date
AU2003226725A8 (en) 2003-10-08
WO2003080617A8 (en) 2003-11-13
GB0207246D0 (en) 2002-05-08
WO2003080617A1 (en) 2003-10-02

Similar Documents

Publication Publication Date Title
AU2002335152A1 (en) Robot-phone
AU2003273865A1 (en) Amino-propanol derivatives
AU2003301968A1 (en) 4-aminomethyl-1-aryl-cyclohexylamine derivatives
AU2003215676A1 (en) Pyrazolopyrimidines derivatives
AU2003229657A1 (en) Triazolopyrimidines
AU2003278369A1 (en) 3-cyano-quinoline derivatives
AU2003296564A1 (en) 4-hydroxymethyl-1-aryl-cyclohexylamine derivatives
AU2003222659A1 (en) 23-o-substituted 5-o-mycaminosyltylonide derivatives
AU2003234131A1 (en) 5-o-mycaminosyltylonide derivatives
AU2003290216A1 (en) Porphyrin derivatives
AU2003206730A1 (en) Fitting
AU2003226725A1 (en) Pyrazolopyrimidine derivatives
AU2002367810A1 (en) Bis-transition-metal-chelate-probes
AU2003273398A1 (en) Aroyl-piperidine derivatives
AU2002249639A1 (en) Pyranocoumarin derivatives
AU2003238180A1 (en) 2-naphtamide derivatives
AU2003288012A1 (en) Isothiazolyl-benzoxazine derivatives
AU2002318053A1 (en) Suplier
AU2002368348A1 (en) Electrosomatogram
AU2003243397A1 (en) Homo-camptothecin derivatives
AU2003284704A1 (en) Substituted 1h-pyridine-2-one derivatives
AU2002348964A1 (en) Snowbike
AU2002341221A1 (en) Honey-brandy
AU2002344387A1 (en) Multifunction-pillow
AU2003235537A1 (en) Amber-climatic complex

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase